linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Cipla Ltd.
 
BSE Code 500087
ISIN Demat INE059A01026
Book Value 419.19
NSE Code CIPLA
Dividend Yield % 1.21
Market Cap 1070996.01
P/E 23.20
EPS 57.14
Face Value 2  
23-Jan-2026 Cipla's consolidated net profit drops 57% in Q3
21-Jan-2026 Cipla inks pact with ImmunoACT to commercialize t...
23-Dec-2025 Cipla launches orally inhaled insulin in India
19-Dec-2025 Cipla informs about updates
11-Dec-2025 Cipla moves up on launching ‘Yurpeak’
10-Dec-2025 Cipla launches ‘Yurpeak’
05-Dec-2025 Cipla completes acquisition of 100% stake in Inzp...
05-Dec-2025 Cipla gains on completing acquisition of 100% sta...
04-Dec-2025 Cipla launches therapy for Knee Osteoarthritis ‘C...
04-Dec-2025 Cipla gains on launching therapy for Knee Osteoar...
29-Nov-2025 Cipla launches integrated lung diagnostics, welln...
04-Nov-2025 Cipla to acquire Inzpera Healthsciences
30-Oct-2025 Cipla reports 4% rise in Q2 consolidated net prof...
30-Oct-2025 Cipla informs about financial results
23-Oct-2025 Cipla enters into agreement with Eli Lilly and Co...
Page 1 of 3
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.